Open Access
CC BY-NC-ND 4.0 · Endosc Int Open 2024; 12(06): E715-E722
DOI: 10.1055/a-2294-8517
Original article

Feasibility and safety of a novel plastic stent designed specifically for endoscopic ultrasound-guided pancreatic duct drainage

1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Yoshikuni Nagashio
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Yuta Maruki
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Akihiro Ohba
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Daiki Agarie
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Yuya Hagiwara
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Hidenobu Hara
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Kohei Okamoto
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Shin Yagi
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Masaru Kuwada
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Mark Chatto
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
2   Department of Medicine, Makati Medical Center, Manila, Philippines (Ringgold ID: RIN37571)
,
Shunsuke Kondo
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Chigusa Morizane
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Hideki Ueno
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
,
Yutaka Saito
3   Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan
,
Takuji Okusaka
1   Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan (Ringgold ID: RIN68380)
› Institutsangaben

This work was supported in part by The National Cancer Center Research and Development Fund 2022-A-16
Preview

Abstract

Background and study aims Endoscopic ultrasound-guided pancreatic duct drainage (EUS-PD) is emerging as an effective alternative treatment for obstructive pancreatitis after unsuccessful endoscopic retrograde pancreatography (ERP). However, the high incidence of adverse events associated with EUS-PD (approximately 20%) remains an issue. Recently, we developed a novel plastic stent for EUS-PD, with a radiopaque marker positioned at approximately one-third of the length from the distal end of the stent and side holes positioned exclusively distal to the marker. This study aimed to evaluate the feasibility and safety of using this stent in EUS-PD.

Patients and methods We retrospectively reviewed data from 10 patients who underwent EUS-PD with the novel plastic stent at the National Cancer Center Hospital between March 2021 and October 2023. Technical and clinical success, procedure times, adverse events (AEs), recurrent pancreatic duct obstruction (RPO), and time to RPO were assessed.

Results Of the 10 patients, five had postoperative benign pancreaticojejunal anastomotic strictures and five had malignant pancreatic duct obstruction. The technical and clinical success rates were both 100% (10/10). An AE (self-limited abdominal pain) occurred in one patient (10.0%). Two patients (20.0%) died of their primary disease during the follow-up period (median, 44 days; range, 25–272 days). The incidence of RPO was 10.0% (1/10), and the 3-month non-RPO rate was 83.3%.

Conclusions The novel plastic stent shows potential as a useful and safe tool in EUS-PD.



Publikationsverlauf

Eingereicht: 16. Dezember 2023

Angenommen nach Revision: 15. Februar 2024

Accepted Manuscript online:
26. März 2024

Artikel online veröffentlicht:
04. Juni 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany